Active and Passive Cigarette Smoking and Mortality Among Hispanic and Non-Hispanic White Women Diagnosed with Invasive Breast Cancer
Overview
Authors
Affiliations
Purpose: Women who smoke at breast cancer diagnosis have higher risk of breast cancer-specific and all-cause mortality than nonsmokers; however, differences by ethnicity or prognostic factors and risk for noncancer mortality have not been evaluated.
Methods: We examined associations of active and passive smoke exposure with mortality among Hispanic (n = 1020) and non-Hispanic white (n = 1198) women with invasive breast cancer in the Breast Cancer Health Disparities Study (median follow-up of 10.6 years).
Results: Risk of breast cancer-specific (HR = 1.55, 95% CI = 1.11-2.16) and all-cause (HR = 1.68, 95% CI = 1.30-2.17) mortality was increased for current smokers, with similar results stratified by ethnicity. Ever smokers had an increased risk of noncancer mortality (HR = 1.68, 95% CI = 1.12-2.51). Associations were strongest for current smokers who smoked for 20 years or more were postmenopausal, overweight and/or obese, or reported moderate and/or high alcohol consumption; however, interactions were not significant. Breast cancer-specific mortality was increased two fold for moderate and/or high recent passive smoke exposure among never smokers (HR = 2.12, 95% CI = 1.24-3.63).
Conclusions: Findings support associations of active-smoking and passive-smoking diagnosis with risk of breast cancer-specific and all-cause mortality and ever smoking with noncancer mortality, regardless of ethnicity, and other factors. Smoking is a modifiable lifestyle factor and effective smoking cessation, and maintenance programs should be routinely recommended for women with breast cancer.
Life's Essential 8 and Cardiovascular Disease in Breast Cancer Survivors.
Ositelu K, Peesay T, Garcia C, Akhter N Curr Cardiol Rep. 2025; 27(1):55.
PMID: 39954113 DOI: 10.1007/s11886-025-02216-9.
Lai Y, Chen Y, Wu Y, Liang F, Wang J, Lim S Cancers (Basel). 2022; 14(19).
PMID: 36230488 PMC: 9558950. DOI: 10.3390/cancers14194565.
Ou Z, Gao Y, Jiang D, Cui J, Ren Y, Tang S Front Oncol. 2022; 12:853038.
PMID: 35425702 PMC: 9001985. DOI: 10.3389/fonc.2022.853038.
John E, McGuire V, Kurian A, Koo J, Shariff-Marco S, Gomez S Cancer Epidemiol Biomarkers Prev. 2020; 30(2):351-363.
PMID: 33355191 PMC: 7867638. DOI: 10.1158/1055-9965.EPI-20-1291.
Prieto D, Soto-Ferrari M, Tija R, Pena L, Burke L, Miller L Health Syst (Basingstoke). 2019; 8(2):75-98.
PMID: 31275571 PMC: 6598506. DOI: 10.1080/20476965.2018.1440925.